Neuroptix Corporation, based in Acton, MA, is a pioneering developer of noninvasive laser eye scanning tests. Specializing in early detection and diagnosis, their cutting-edge technology is utilized to identify Alzheimer's disease in its early stages.
By offering predictive scanning tests, Neuroptix Corporation is at the forefront of advancing diagnostic capabilities for Alzheimer's disease. Their innovative approach holds promise for improving patient outcomes through early intervention and treatment.
Generated from their available business information
